Literature DB >> 23863941

Cell biology: tumour stem cells in bone.

Mone Zaidi, Simón Méndez-Ferrer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23863941      PMCID： PMC4130648          DOI： 10.1038/nature12412

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

Review 1.  Cathepsin K, osteoclastic resorption, and osteoporosis therapy.

Authors:  M Zaidi; B Troen; B S Moonga; E Abe
Journal:  J Bone Miner Res       Date:  2001-10       Impact factor: 6.741

2.  Special stem cells for bone.

Authors:  Mone Zaidi; Li Sun; Harry C Blair
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

3.  PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects.

Authors:  Maria I Kontaridis; Kenneth D Swanson; Frank S David; David Barford; Benjamin G Neel
Journal:  J Biol Chem       Date:  2005-12-23       Impact factor: 5.157

Review 4.  Skeletal remodeling in health and disease.

Authors:  Mone Zaidi
Journal:  Nat Med       Date:  2007-07       Impact factor: 53.440

5.  Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration.

Authors:  Dongsu Park; Joel A Spencer; Bong Ihn Koh; Tatsuya Kobayashi; Joji Fujisaki; Thomas L Clemens; Charles P Lin; Henry M Kronenberg; David T Scadden
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

6.  Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels.

Authors:  Christa Maes; Tatsuya Kobayashi; Martin K Selig; Sophie Torrekens; Sanford I Roth; Susan Mackem; Geert Carmeliet; Henry M Kronenberg
Journal:  Dev Cell       Date:  2010-08-17       Impact factor: 12.270

7.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.

Authors:  Simón Méndez-Ferrer; Tatyana V Michurina; Francesca Ferraro; Amin R Mazloom; Ben D Macarthur; Sergio A Lira; David T Scadden; Avi Ma'ayan; Grigori N Enikolopov; Paul S Frenette
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

Review 8.  The tyrosine phosphatase Shp2 (PTPN11) in cancer.

Authors:  Gordon Chan; Demetrios Kalaitzidis; Benjamin G Neel
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

9.  Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

Authors:  Takashi Nakamura; Yuuki Imai; Takahiro Matsumoto; Shingo Sato; Kazusane Takeuchi; Katsuhide Igarashi; Yoshifumi Harada; Yoshiaki Azuma; Andree Krust; Yoko Yamamoto; Hiroshi Nishina; Shu Takeda; Hiroshi Takayanagi; Daniel Metzger; Jun Kanno; Kunio Takaoka; T John Martin; Pierre Chambon; Shigeaki Kato
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

10.  Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia.

Authors:  Shozeb Haider; Barira Islam; Valentina D'Atri; Miriam Sgobba; Chetan Poojari; Li Sun; Tony Yuen; Mone Zaidi; Maria I New
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205
View more
  2 in total

1.  Targeting cancer's weaknesses (not its strengths): Therapeutic strategies suggested by the atavistic model.

Authors:  Charles H Lineweaver; Paul C W Davies; Mark D Vincent
Journal:  Bioessays       Date:  2014-07-14       Impact factor: 4.345

2.  The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function.

Authors:  Joan Isern; Andrés García-García; Ana M Martín; Lorena Arranz; Daniel Martín-Pérez; Carlos Torroja; Fátima Sánchez-Cabo; Simón Méndez-Ferrer
Journal:  Elife       Date:  2014-09-25       Impact factor: 8.140
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.